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Abstract
Background: As in other European countries, the French vaccination schedule changes according to epidemiological and
socio-economic situations. Further changes are planned for 2013, including the withdrawal of one dose for primary
vaccination against diphtheria, tetanus, polio, pertussis and Haemophilus influenzae. A partnership between the French
Technical Vaccination Committee and the French Institute for Health and Medical Research designed a study to assess
primary care physicians’ agreement about this modification.
Methods: Qualitative study with focus groups and semi-structured interviews in France. Four focus groups were conducted
with physicians, supplemented by four individual interviews.
Results: The physicians of the survey had accepted the suggested vaccination schedule well. A few concerns had been
underlined: fear of less follow-up care for infants resulting from the removal of one visit driven by the primary vaccination;
fear of loss of vaccine efficacy; suspicion of the existence of financial arguments at the origin of this change; and adjustment
to current vaccination schedule. Several suggestions were made: providing strong support from health authorities;
developing stable and simple recommendations; providing effective tools for monitoring patient’s vaccination status.
Conclusions: Physicians’ opinions suggested a good acceptance of a possible change about primary vaccination against
diphtheria, tetanus, polio, pertussis and Haemophilus influenzae. Physicians’ suggestions resulted from this qualitative study
on a new vaccination schedule. It showed how that their involvement was feasible for preparing the implementation of a
new vaccination schedule.
Keywords: Qualitative research, Vaccination, Primary care
Background
In France, children receive seven doses of vaccine against
diphtheria, tetanus and inactive polio virus (DT-IPV) before
the age of 18 years, including four doses before the age of
2 years [1]. France is one of the European countries in
which children receive the greatest number of injections
[2]. Before the age of 2-years old, two vaccination schedules
for DT-IPV exist in the world. They recommend either
three or four doses. Several studies have suggested that the
primary vaccination with three doses for DT-IPV (at the
age of 3, 5 and 11–12 months) would be sufficient and ef-
fective [3-5]. In 2009, four European countries had adopted
this vaccination schedule (Denmark, Norway, Italy and
Sweden) [2]. In 2012, the French Technical Vaccination
Committee (CTV) had studied the possibility of reducing
one dose of DT-IPV vaccine in childhood vaccination be-
fore the age of 2 years. This discussion was part of a
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broader debate including the DT-IPV vaccination after the
age of 2 years, but also others vaccinations such as vaccina-
tions against whooping cough or measles This new calen-
dar has been edited in April 2013 and available on the
French Institute for Public Health Surveillance website
[www.invs.sante.fr] [6]. In France, DT-IPV vaccination is
compulsory since 1965. Changing this vaccination may rep-
resent a deep change. The Public Health High Council and
particularly Technical Vaccination Committee are in charge
of vaccination strategies development in France. The Min-
istry of Health validates and implements their notices. Each
year a new calendar is edited with past and new recom-
mendations. Even if DT-IPV vaccination’s coverage was
91.5% in 2007, this deep change in DT-IPV vaccination is
like a small revolution in France [7]. Because of this, it ap-
pears necessary for the CTV to assess primary care physi-
cians’ agreement prior to this modification. This agreement
is necessary to get high vaccination coverage [8]. Vaccin-
ation against A (H1N1) influenza virus during the 2009
pandemic is a perfect example of the major role of GPs in a
mass vaccination [9]: while GPs were initially very support-
ive of this vaccination [10], public authorities did not in-
volve them in the vaccination campaign for logistical
reasons. Patients were vaccinated in hospitals or in dedi-
cated vaccination units. Overall, the vaccination campaign
resulted in poor vaccination coverage (7.9%) [11]. In the
field of childhood primary vaccination, implementation of
measles vaccination confirmed that the new recommenda-
tion is a long learning. Since first dose of measles vaccine
recommendation in 1983, the vaccine coverage rate of 95%
has not been reached [12], and took nearly 10 years to
reach 80% (32% in 1985, 80% in 1994) [13].
The first aim of this study was to examine the percep-
tions of primary care physicians about a change DT-IPV
vaccination. Secondary objectives were to understand their
needs for the implementation of the new vaccination
schedule and to investigate the perceptions of primary care
physicians in relation to parental acceptance of the annual
changes in vaccination schedule.
Methods
Participant recruitment procedure
Qualitative method was used with focus groups and semi-
structured interviews [14-16]. These methods are more ap-
propriate than quantitative ones to study the variety of
opinions and feelings of the actors, and to generate new hy-
potheses. The focus groups are a dynamic group of discus-
sions to gather information, assess needs, behaviours, and
various views of a target population on a given subject. The
semi-structured individual interviews were used to collect
similar information from individuals who were not able to
participate in focus groups (for example working in rural
areas or being too busy). Those methods are used to exam-
ine physicians’ immunization behaviour [17-19]. Four focus
groups with primary care physicians, supplemented by four
semi-structured interviews were performed in France. Two
medical specialties take care of children in French primary
care: general practitioners (GPs) and paediatricians. In 2011,
they respectively represented 96% and 4% of those physi-
cians [20]. It was decided to set up focus groups for these
two different specialties.
Focus groups were conducted between April and July
2012, and individual interviews between July and Septem-
ber 2012. The study population was drawn from different
regions of France. Participants were selected among local
contacts and among physicians belonging to a network
(the French GPs Sentinelles network [21], or the French
Association of Ambulatory Paediatrics (AFPA)). Physi-
cians who gave their consent were contacted by telephone
to answer questions: number of years since installation,
proportion of children seen in consultation, practicing
complementary and alternative medicine, member of a
network and teaching activity. Considering these answers,
groups of participants as heterogeneous as possible were
built to obtain maximum variation sampling. Each focus
group included younger and older, more experienced phy-
sicians, male and female, from both urban and rural areas.
The focus groups had to gather six to twelve people, re-
cruitment stopped when the number of participants was
in this range. Anti-vaccination physicians were excluded
from this selection. As they did not participate to vac-
cination campaign, they would not have been able to
bring any interesting information to this study. Vaccin-
ation schedule modification would have little or no con-
sequences on a non-vaccinating physician’s practice.
To test data saturation of focus groups (a situation in
which data has been heard before), individual semi-
structured interviews were conducted with GPs who
could not participate in focus groups, which completed
the focus groups’ results.
Data collection
A topic guide was developed (Table 1), checked and vali-
dated by the study scientific committee, and tested by tele-
phone with two GPs. This document included fifteen
open-ended questions used by the moderators as a frame
to animate exchanges. Recovery questions were planned if
the moderator noted a decline in the group’s dynamism.
The first part of the interview focused on physicians’ opin-
ions and experiences concerning vaccination: their percep-
tions and practices concerning the current vaccination
schedule, as well as motivations and barriers encountered
in its implementation. Secondly, the interview gathered
physicians’ reactions concerning the modifications planned
by the CTV and their wishes for the implementation of this
new vaccination schedule. For each focus group, a trained
moderator led the discussion to ensure that all topics of
the study were discussed and that all physicians were
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involved in the discussion. Focus groups were observed by
a researcher who gathered information on non-verbal com-
munication and interaction between participants. One in-
vestigator led all individual interviews by telephone with
the same topic guide to avoid methodological bias. Audio
recordings of the focus groups and the individual interviews
were done, and these recordings were transcribed.
Analysis
A thematic approach was used. From the transcript of re-
cords, two researchers each created a code list based on the
verbatim quotes. These codes were shared and discussed
within the research team. The codebook was continuously
revised in order to compare all of the codes and to clarify
their meaning, going back to the context until mutual con-
sent was reached. The final thematic list was submitted to
the Scientific Committee and discussed with its members.
Ethics statement
This study has been conducted by the Sentinel network.
The Sentinel network is regulated by the mixed research
unit UMR-S 707 of INSERM and University of Paris VI:
Pierre and Marie Curie, in collaboration with the French
Institute for Public Health Surveillance (Institut de veille
sanitaire, InVS). It has obtained a research authorisation
from the French independent administrative authority
protecting privacy and personal data (CNIL), n°471 393.
The ethical approval from the ‘National Commission for
Computing and Liberties’ (‘Opinion No. 471393, September
1996’) had been given for continuous surveillance of health
indicators and for some specific studies, which do not in-
volve human participants. Specific ethical approval is not
required for this study
Results
Four focus groups and four individual interviews, involv-
ing 45 physicians, were carried out. Data saturation was
reached after four focus groups, and the four individual
interviews did not bring any additional themes or
sub-themes. The selection process resulted in a hetero-
geneous study population. The characteristics of the par-
ticipants are summarised in Table 2. Each quote is the
comments expressed by one physician, although they
can be agreed, moderated or disproved by the other par-
ticipants. Each quote was chosen because it best repre-
sents recurring ideas arising from discussions.
Current vaccination schedule
According to the study’s physicians (Table 3), most pa-
tients accepted vaccinations without difficulty (Quote 1).
Protection against serious diseases was one of the main
reasons to get vaccinated. Some vaccines names can be
very persuasive for being vaccinated (Quote 2). A trust-
worthy relationship between physicians and patients
would be helpful (Quote 3). It has been found that a
wide dissemination of information on vaccines was use-
ful, particularly through the mass media campaign
(Quote 4). Compulsory vaccination appears to promote
physicians’ and patients’ compliance with the vaccination
Table 1 Topic guide
Questions Reopening
First ice breaking question: we are going to talk about regular
changes of the vaccination schedule. At first, could you tell us how
do you use the vaccination schedule in your daily practice?
Regarding the children/infants? How do you explain it to the
parents
Why do you face some difficulties? How do you resolve any possible conflicts or misunderstandings?
Do these changes seem justified to you? How would you explain these changes? Why would it be a problem?
In order to make the current vaccination schedule easier, a work group of the French Technical Vaccination Committee would possibly reduce the number
of injections administered to infants from 4 to 3 injections between 0 and 18 months of DT-IPV-Ca-Hib¥. This would imply an important modification
of the actual vaccination schedule.
How, in terms of acceptability, usefulness, feasibility, and impact on
practices, would you react to such a change?
Would you need more scientific evidence?
Do you think that this change will be understood or accepted by the
family of the children involved (a priori and/or based on past experience)?
What level of proof do you need a priori?
How do you plan to apply these changes? Would you be willing to incorporate this change into your practice?
What would be your condition(s) to apply? If you are not ready or
disagree, why?
What are your wishes for the implementation of the revised schedule? If such a change took place, what are the best ways for you to set it up?
What do you think of the current means to broadcast new
recommendations?
What tools would you like to get in order to make access to information
easy about the foreseen change?
What tools are currently available to you? Which ones do you use?
Compared to those you already have, do you think they should be
improved? Multiplied?
¥Vaccine against diphtheria, tetanus, inactive polio virus, whooping cough and Haemophilus b.
Lungarde et al. BMC Family Practice 2013, 14:85 Page 3 of 8
http://www.biomedcentral.com/1471-2296/14/85
schedule. The reimbursement of the vaccines seems to
improve the acceptance of vaccination (Quote 5).
Most physicians of this survey encountered difficulties in
adapting quickly to regular vaccination schedule changes
(Table 4). They noticed that these changes influence pa-
tient’s acceptance and induce problems concerning catch-
up schedules (Quote 6). Introduction of new vaccines into
the vaccination schedule would create more difficulties
with respect to the existing vaccine. Finally they seemed to
consider that the vaccination schedule got more and more
complicated (Quote 7). The participants suggested differ-
ences in physicians’ practices. This could cause additional
problems in convincing patients of the vaccination’s value
(Quote 8). Physicians expressed a lack of scientific evidence
for the changes in the vaccination schedule (Quote 9).
They wished for a better visibility of this scientific evidence
by the Health Authorities. According to them, one recur-
rent problem was missing opportunities of vaccination.
Written materials, such as health records or vaccination
cards were often lost or non-existent (Quote 10). Physi-
cians wanted to improve the dissemination of information
to patients in order to decrease patient’s refusal and im-
prove awareness of recommendations (Quote 11). The
negative effects of the media had probably increased the
fear of side effects (Quote 12). According to participants,
patients would distrust health authorities (Quote 13). The
physicians felt a disengagement of these authorities and
would like more support from them.
The vaccination schedule proposed
Supposing that the number of injections of DT-IPV before
the age of 2 years was reduced, all participating physicians
had a favourable opinion. According to them (Table 5),
children were more anxious and sensitive regarding injec-
tions before the age of 2 years. Reducing the number of
vaccines for infants would be less problematic than adding
an extra dose of vaccine or a new vaccine (Quote 14). The
physicians also paid attention to this modification, improv-
ing the physician-patient relationship, if vaccine efficacy re-
mains the same. They could see the children and their
parents more peacefully when no vaccination was planned.
According to them, parents would accept that one dose of
vaccine is removed from the vaccination schedule (Quote
15). Vaccinating infants against DT-IPV in a shorter period
than the current schedule would be seen as an advantage.
The interviewed physicians reported that receiving prime
vaccines during the first 12 months would facilitate adhe-
sion to vaccination schedule (Quote 16). A fixed age
concerning DT-IPV booster dose for adults was consid-
ered as an advantage to facilitate the implementation of
the new vaccination schedule (Quote 17). Some physicians
reported that they sometimes adapted their vaccination
practices before the schedule’s changes, according to sci-
entific reading or personal positions (Quote 18).
Physicians questioned the possible risk of less frequent
monitoring of children (Table 6). Vaccination was an op-
portunity for children’s routine physical check-up (Quote
19). For some modifications, the question of vaccine effi-
cacy remained (Quote 20). The physicians paid a lot atten-
tion to be sure that vaccination schedule changes would
not come from financial influences (Quote 21). Physicians
had always difficult to keep up with the frequent changes
in vaccination schedule (Quote 22).
All participating physicians wanted to have scientific
evidence supporting the vaccine efficacy despite changes
to the vaccination schedule and no side effects induced
by the latter (Quote 23) (Table 7). In order to implement
more easily the new vaccination schedule, physicians
wished to have support from the political and health au-
thorities. Physicians wished to enhance communication
with patients and health authorities about the import-
ance of vaccines. They frequently mentioned that there
was a need to be supported from the health authorities.
Some said that their mission was not to convince patients
but that it was the health authorities’ responsibility. Mass
campaign media for vaccinations could help to reduce
anti-vaccine activity (Quote 24). According to some physi-
cians, improving communication around vaccination could
facilitate uptake of the vaccination schedule (Quote 25). If
patients trust in vaccines and vaccination, physicians would
not have difficulties in practicing it. They also suggested
that informing health care practitioners about the new vac-
cination schedule by individual letters would facilitate its
Table 2 Physicians’ profiles and practices
Primary care
physicians
(N = 45)
Medical specialties: General
practitioner / Paediatric
36 / 9
Sex: Male / Female 23 / 22
Age, mean (min-max) 50 (32–66)
Number of years since installation,
mean (min-max)
18 (1–35)
Proportion of children of their activity:
Children under 16-years old (%),
mean (min-max)
43 (10-100%)
Working area, n (%)
Rural practice 14 (31%)
Urban practice 23 (51%)
Mixed practice 8 (18%)
Practicing complementary and
alternative medicine n (%)
3(7%)
Group practice n (%) 24 (53%)
Teaching activity n (%) 14 (31%)
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implementation (Quote 26). They considered simplifying
vaccination policies as a priority, even if it means losing ac-
curacy (Quote 27). They expressed difficulties to read the
entire recommendations, which were too longer or too de-
tailed. Improving vaccination educational materials for
healthcare providers could more easily identify people who
should be vaccinated. Two types of tools were discussed:
those for health professionals and those for patient educa-
tion (Quote 28). They also put forward the efficacy of using
computer tools (Quote 29).
Discussion
French modification of the infants DT-IPV primary vac-
cination seems possible and acceptable. The preliminary
evaluation of the acceptability of this modification by
primary care physicians has highlighted some main points
that will facilitate the implementation of the new vaccin-
ation schedule:
~Scientific justification and health authorities’ support
~Simplicity and stability of vaccine recommendations
~Tools to help management of vaccinations
Physicians needed strong scientific evidences to justify
the new vaccination recommendations. These justifications
involve health authorities’ support. At the international
level, the objectives are based on transparency and clarity
on vaccination strategies [22]. Reviews and reports of the
Public Health High Council, in charge of vaccination strat-
egies development in France, are available on their website
Table 3 Conditions leading to the easy application of the vaccination schedule
Quote
number
Theme Verbatim
Quote 1 Acceptance of the patient « I rarely meet people who refuse » (FGR male, GP, 57, rural practice)
Quote 2 Vaccines and their power of
persuasion
« It’s easier for parents to accept vaccines that are unknown to the public, for instance, the
meningococcal C vaccine. Because there is the magical word. The word “meningitis” is scary…! » (FG
paediatrician, female, 62, urban practice)
Quote 3 Physician-patient
relationship
« They trust their GP, their family physician. If the physician is not that sure, it is less probable that the
vaccination will be done » (FGR, man, GP, 50, mixed practice)
Quote 4 Broadcasting information « Meningitis, (…) it is widely understood (…) because there have been cases and this information has
been broadcasted » (FGR, female, GP, 40, rural practice)
Quote 5 Vaccine reimbursement « (…) As long as vaccine is reimbursed, [it is easier] to obtain their consent for vaccinations » (FGR, man,
GP, 55, urban practice)
GP General Practitioner, FG Focus Group.
Table 4 Perceived barriers to vaccination
Quote
number
Theme Verbatim
Quote 6 Patient misunderstanding « At school, people say : “how come you haven’t been vaccinated by your physician ?” (then we answer)
“But at that time, it (the vaccination schedule) was different.” To people’s eyes, we’ve become less
trustworthy. » (FGF, female, GP, 47, rural practice)
Quote 7 Complexity of indications « I mean, given the actual criteria encouraging the practice of BCG vaccination (…), telling the patient
whether or not to get vaccinated, according to his geographic and ethnic origins, it is not always
obvious.» (FGR, man, GP, 50, mixed practice)
Quote 8 Different medical practices « It is difficult for me to give a different medical advice by saying "Hepatitis B vaccine, let’s go for it!"
while another physician told the same patient not to get vaccinated immediately » (FGF, man, GP, 43,
mixed practice)
Quote 9 Lack of scientific justification « There still isn’t any evidence showing the efficacy of HPV vaccine» (FGP, man, GP, 57, urban practice)
Quote 10 Inadequate aftercare « I met two young girls who (…) came to see me without their child health notebooks. They were
7- and 9-years old, I was wondering which vaccine to administrate? No one could tell me which
vaccines they have had since birth. » (FGF, female, GP, 58, rural practice)
Quote 11 Insufficient information
broadcasting
« I also have the feeling that there is little information broadcasted at the national level, I would say
generally that we are the only ones who give this information, thereby losing our credibility as
physicians » (FGR, man, GP, 57, rural practice)
Quote 12 Negative impact of mass
media campaign
« I got the feeling that patients lose trust in medication, especially vaccines. I think that the mass media
campaign around the influenza A(H1N1) vaccination led to bad publicity. I experience this unwavering
mistrust in my daily practice; for instance, when you were referring to the hepatitis B vaccine episode,
which has deeply marked patients and physicians. » (FGR, man, GP, 50, mixed practice)
Quote 13 Mistrust of institutions « As for me, I still have the feeling that there is a great loss of trust from the patients toward the public
authorities, be it the media or even the official authorities. » (FGR, man, GP, 39, rural practice)
GP General Practitioner, FG Focus Group.
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[www.hcsp.fr]. Their availability and reading can respect
this principle. Even if scientific justification is a determin-
ing factor, it is not sufficient in itself, as shown by the ex-
ample of hepatitis B vaccination. Despite Public Health
High Council in 2004 showed no evidence of a link be-
tween hepatitis B vaccination and demyelinating diseases,
the infants’ vaccination coverage at the age of 24 months
reached only 41.9% in 2007 [7].
In 1996, Pathman et al. developed a four-step model ne-
cessary for the use of clinical guideline recommendations,
particularly on paediatric vaccine usage [23]. These four
steps are awareness, agreement, adoption and adherence.
Adherence was defined for a physician as 90% or greater
of their patients received the vaccine as recommended.
Mickan et al. realised in 2011 a meta-analysis on the im-
plementation of the recommendations in the United
States on various medical fields [24]. The authors showed
progressive drop off with the proportion dropping off at
each step at about 15%. Awareness of the recommenda-
tion is only one of these four steps to improve profes-
sional’s practice [23]. When changing the DT-IPV infant
primary vaccination, health authorities would have to
work on each step to obtain high coverage.
The acceptance of this modification was balanced by
physician’s needs to have a stable and simple vaccination
schedule. Even if regular changes are required to follow the
evolution of advanced vaccinology and epidemiological
characteristics, their impact on the health professional’s
practices should be taken into account. In Great Britain,
two years after the cessation of routine BCG vaccination in
2005 and the implementation of targeted vaccination, two-
thirds of parents and professionals interviewed were not
aware of the new recommendation [25]. About multiplying
specific indications, a French study of 2009 on the determi-
nants of BCG vaccination showed that the probability of an
eligible child being properly vaccinated increased with the
number of instructions known by the physician [26].
From a practical point of view, demand for developing
specific tools to help track the vaccination status of their
patients was high among the physicians interviewed. A
study in the US showed that the use of a computerised
medical record increased opportunities for updating chil-
dren’s vaccinations and vaccinated them earlier [27]. How-
ever, the role of computerised vaccination alerts would be
uncertain. Two studies in the US have shown a significant
increase in vaccination coverage through the use of
computerised vaccination alerts in obstetrics and gynaecol-
ogy, and rheumatology departments [28,29]. In primary
care, this effect has not been demonstrated in a study [30].
It would be interesting to evaluate the effectiveness of
Table 5 Strengths of the proposed vaccination schedule mentioned by physicians
Quote’s
number
Theme Verbatim
Quote 14 Lowering the frequency of DT-
IPV injections
« The interesting thing is that there is no need to repeat the injection at 3 months. This allows me to
finally (…)meet them again in 3 months’ time without any vaccination …» (FGR, female, GP, 40, rural
practice)
Quote 15 Patient adherence « I think that they [parents] should be happy that there are fewer [injections]» (FGF, female, GP, 58,
rural practice)
Quote 16 Primary vaccination shorter « This is an additional motivation for applying such a scheme. » (FGF, female, GP, 47, rural practice)
Quote 17 Vaccination at a given age « Vaccinated at a fixed age, it will be easier than managing the immunization schedule based on
time or latency » (FGR, man, GP, 57, rural practice)
Quote 18 Anticipatipating some changes « About the measles-mumps-rubella vaccination : "Well, to be honest, I have anticipated the new
recommendations (laughs) I do it for everyone at age nine ! (…) And then it allows me to give the
Prevenar ® along with the meningococcal C at 12. So in the calendar you describe here, well, the
potentially calendar-to-be, it is the same as my current practice. » (EI1, man,GP, 32 , rural practice)
GP General Practitioner, FG Focus Group.
Table 6 Possible barriers for applying the proposed vaccination schedule
Quote’s
number
Theme Verbatim
Quote 19 Less aftercare for young
children
« Would parents bring us their 16/18-months old child if there is no vaccine to do? » (FG paediatrician,
female, 58, urban practice)
Quote 20 Doubts about vaccination
effectiveness
« It makes me sick to see them vaccinated at nine months, I think that's a false security because they are
not protected » (FG paediatrician, female, 62, rural practice)
Quote 21 Fearing a financial
motivation
« If it's only tied to an economic reason, then it is not reliable anymore » (FGR, man, GP, 57, rural
practice)
Quote 22 Hard catch-up vaccination
schedule
« It is difficult to get used to changes » (FGF, female, GP, 57, rural practice)
GP General Practitioner, FG Focus Group.
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computer tools in the modification of the DT-IPV infant’s
primary vaccination. With the development of innovative
tool like mesvaccins.net, vaccination coverage may be bet-
ter. This application can be used in France both by physi-
cians and patients to know when and which vaccine are
recommended. It is update regularly. For nowadays it is
not available for medicine software. This could be some-
thing to work.
Asking upstream the local providers about vaccin-
ation schedule changes is innovative. Another strength
of the study was to obtain heterogeneous focus groups,
supplemented by four semi-structured interviews. This
permitted to raise most important barriers to imple-
mentation of the new calendar. Otherwise the study has
several limitations. First, the sampling method might
have caused selection bias, including physicians belong-
ing to a network (the French GPs Sentinelles network,
or the French Association of Ambulatory Paediatrics
(AFPA)). Second, physician has indirectly described par-
ents’ demands, in addition of their own perception.
Other study should be done to confirm these results.
Third, the qualitative data might have been influenced
by interpretation bias, despite efforts to reduce such
bias. These included double data analysis and discussion
of the data with the research team. Fourth, the results of
the collection of observational data (non-verbal behav-
iour of the participants) have not been fully exploited.
Conclusion
This qualitative study provides an overview of physicians
‘perceptions about a change in the DT-IPV infants’ pri-
mary vaccination. The most important result was the
favourable opinions of the physicians towards this change.
To implement this change, they suggested some interven-
tions, as communication campaign to both physicians and
parents, and strong scientific background. This positive ex-
perience has enabled collaboration between practitioners
and those responsible for developing recommendations.
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Table 7 Physicians’ wishes for implementing the proposed vaccination schedule
Quote’s
number
Theme Verbatim
Quote 23 Strong scientific justification « (…) There are articles every day about the side effects and some people are getting convinced by
physicians who are against vaccines. So if we have something to present we need to be unassailable. »
(FG, paediatrician, man, 57, urban practice)
Quote 24 Strong support from health
authorities
« I think we should take the opportunity to make a good communication campaign, we often hear
from the anti-vaccine lobby, it would be good to hear the voice of competent authorities … » (FG,
paediatrician, female, 62, urban practice)
Quote 25 Informing the population « Perhaps there should be a communication like has been done about antibiotics … which went well
by the way - inform people » (FGF, female, GP, 47, rural practice)
Quote 26 Informing healthcare
professionals
« What would be interesting is that as soon as they change something, they broadcast that to all
physicians with leaflets and emails we do receive » (FGF, female, GP, 45, urban practice)
Quote 27 Simplifying vaccination
policies
« It is better to have a simple calendar, easy to apply, that we will apply, rather than an ideal but
complicated one, that we will not apply because it is too difficult to do …» (FGF, man, GP, 55, mixed
practice)
Quote 28 Improving vaccination
educational materials
« Those [recommendations] to be sent to patients, they must be simple. So that they get it right, and
that it may be a schedule to give to them, and we'd put on the vaccination page, on top of that
already exists. " (EI4 man, GP, 65, mixed practice)
Quote 29 « I expect a lot of universal electronic records in this case. Because it may allow us to have eyes on the
reality of vaccinations » (FGR, man, GP, 57, rural practice)
GP General Practitioner, FG Focus Group.
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